What are the limitations of the rosendaal ttr?

While the rosendaal ttr is highly validated, it should not replace clinical judgment. OpiCalc provides the latest evidence-based limitations for the rosendaal ttr to ensure safe bedside use and optimal diagnostic accuracy.

How does the rosendaal ttr compare to other hematology scores?

The rosendaal ttr is a gold-standard diagnostic tool. OpiCalc provides side-by-side clinical guidance to help clinicians choose the most specific evidence-based tool for their patient's presentation.

Is the rosendaal ttr free to use?

Yes. OpiCalc provides the rosendaal ttr completely ad-free and optimized for mobile bedside use, ensuring you can calculate medical risk swiftly and without distraction.

OpiCalc

927 Clinical Tools

OpiCalc

4Ts Score (HIT)aaIPI (Age-adjusted IPI)ABC Score (Massive Transfusion)Absolute Neutrophil Count Age-adjusted D-dimer Threshold aGvHD Grading (Glucksberg/MAGIC)AL Amyloidosis Staging (Mayo)Anti-Xa Monitoring Interpreter Antiphospholipid Syndrome Classification Binet / Rai Staging (CML)Blood Volume Calculator Caprini VTE Risk CISNE Score CLL-IPI Coombs-Negative Haemolysis Checklist Corrected Reticulocyte Count CRS Grading (ASTCT 2019)DAT Interpretation Algorithm Deauville Score Interpreter DIC Score (ISTH)DIPSS (MF)DIPSS-Plus (MF)DOAC Dose Selector DOAC Renal Dose Adjustment DRI (Disease Risk Index)Durie-Salmon Staging (historical)EBMT Risk Score ELN 2022 AML Risk Classification ELTS Score (CML)England & Fraser Index EUTOS Score (CML)Expected Hb Rise per RBC Unit Factor Inhibitor Bethesda Titre Interpreter Febrile Neutropaenia Risk (MASCC)Fibrinogen Replacement FLIPI (Follicular Lymphoma IPI)FLIPI-2 French TTP Score GAPSS (Global APS Score)Haemophilia Severity Classification HbS Percentage Target Calculator HCT-CI (Comorbidity Index)HEP Score Heparin Nomogram (Weight-based)Hepatic Iron Index HERDOO2 Rule HFE Haemochromatosis Risk Estimator ICANS Grading (ASTCT 2019)IMWG Response Criteria (Myeloma)IPI (International Prognostic Index)IPSID / Lugano Classification IPSS-M (Molecular IPSS)IPSS-R (Revised IPSS for MDS)Iron Deficit Calculator (Ganzoni Formula)ISS (Myeloma)ISTH Bleeding Assessment Tool (BAT)ISTH Non-Overt DIC Score ITP Bleeding Score iwCLL Response Criteria (2018)IWG ITP Response Criteria JAK2V617F Allele Burden Interpreter Karnofsky Performance Scale Leucostasis Risk Threshold Lupus Anticoagulant (LAC) Reporting Framework MAGIC aGvHD Biomarker Score MCV-based Anaemia Algorithm Mentzer Index MIPI (MCL IPI)MIPSS70+ v2.0 (MF)Mixing Study Interpretation MRD Assessment Threshold Interpreter mSMART 3.0 (Myeloma)MTP Activation Criteria NCCN-IPI NIH Chronic GvHD Scoring NTDT Iron Burden Estimator Padua RAM PBT (Paediatric BAT)PCNSL MSKCC Score PERC Rule Perioperative Anticoagulation Bridging PESI Score (PE Mortality)PLASMIC Score Platelet Increment Calculator (CCI)PNH Clone Size Interpreter R-IPI (Revised IPI)R-ISS (Revised ISS)Reticulocyte Index (RPI)Revised Geneva Score (PE)Revised Response Criteria (NHL)Revised Zubrod / ECOG Performance Shine & Lal Index Sickle Cell Disease Risk (TCD)SLiM-CRAB Criteria SOKAL Score (CML)Sokal/EUTOS/ELTS Comparison sPESI (Simplified PESI)TACO Risk Score Thalassaemia Transfusion Threshold Thrombocytopaenia Differential Thrombophilia Screening Eligibility Algorithm Time in Therapeutic Range (TTR)TLS Risk Classification Transferrin Saturation Calculator Vienna Prediction Model von Willebrand Factor Activity Interpreter Warfarin Dose Calculator Wells Score (DVT)Wells Score (PE)WHO 2022 AML Classification Mapper WHO Bleeding Scale YEARS Algorithm

Time in Therapeutic Range (TTR)

TTR Calculation: The Rosendaal method uses linear interpolation to estimate time in therapeutic range. A TTR > 65% is standard for stable anticoagulation.

Total Monitoring Period (Days)

Interpolated Days In-Range (INR 2-3)

Guidelines & Evidence

Clinical Details

Section 1

When to Use

Assessing the stability and quality of anticoagulation in patients on Vitamin K Antagonists (Warfarin).

Identifying patients at high risk of stroke or bleeding due to sub-optimal TTR (< 60%).

Decision support for transitioning from Warfarin to a DOAC (if TTR remains persistently low).

Target Range

Clinical stability is generally defined as a TTR > 65% – 70%. Values below 60% are associated with significantly worse outcomes.

Section 2

Formula & Logic

The Rosendaal Linear Interpolation

The Rosendaal method assumes that the INR between two measurements changes linearly. For example, if an INR is 2.0 on Day 1 and 3.0 on Day 5, it is assumed that the INR was "in range" for all 4 intervening days.

Limitations

Requires at least two INR readings separated by time.

Does not account for diet or medication changes that cause abrupt jumps.

Best calculated over a period of ≥ 6 months for stability assessment.

Section 3

Pearls/Pitfalls

SAMe-TT₂R₂ Score Correlation

A low TTR often reflects clinical complexity, poor adherence, or genetic resistance. If a patient cannot maintain a TTR > 65% despite regular monitoring and dose adjustments, switching to a DOAC (which provides 100% "time in range" by default) is strongly recommended.

Section 4

Evidence Appraisal

Primary Consensus

A method to determine the optimal intensity of oral anticoagulant therapy.

Rosendaal FR et al. • Thrombosis and Haemostasis. 1993;69(3):236-9.

View Source

Section 5

Literature

Gold Standard

Developed in the early 90s, the Rosendaal method became the global regulatory standard for defining the "safety" of warfarin in almost every major DOAC registrational trial (RE-LY, ARISTOTLE, ROCKET-AF).

Last Comprehensive Review: 2026

Related Hematology Tools

ITP Bleeding Score

IWG ITP Response Criteria

WHO Bleeding Scale

Thrombocytopaenia Differential

Warfarin Dose Calculator

DOAC Dose Selector

DOAC Renal Dose Adjustment

Heparin Nomogram

Anti-Xa Monitoring Interpreter

Perioperative Anticoagulation Bridging

Have feedback about this calculator?Let us know.

Time in Therapeutic Range (TTR)

TTR Calculation: The Rosendaal method uses linear interpolation to estimate time in therapeutic range. A TTR > 65% is standard for stable anticoagulation.

Total Monitoring Period (Days)

Interpolated Days In-Range (INR 2-3)

Guidelines & Evidence